Glaxosmi. Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE159A01016
  • NSEID: GLAXO
  • BSEID: 500660
INR
2,592.50
17.45 (0.68%)
BSENSE

Dec 16

BSE+NSE Vol: 44.33 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryGlaxosmi. Pharma VS Pharmaceuticals & Biotechnology
 
1D
0.68%
-0.63%
1W
1.27%
0.02%
1M
4.62%
0.14%
YTD
15.39%
8.37%
1Y
13.76%
3.59%
3Y
93.09%
38.05%
5Y
67.09%
81.46%
10Y
57.91%
232.15%
  • Stock Absolute Returns
  • Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-5.56%
0%
-5.56%
6 Months
-22.99%
0%
-22.99%
1 Year
13.76%
0%
13.76%
2 Years
46.26%
2.43%
48.69%
3 Years
93.09%
5.77%
98.86%
4 Years
46.22%
7.87%
54.09%
5 Years
67.09%
10.60%
77.69%

Latest dividend: 12 per share ex-dividend date: Nov-07-2024

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Inconsistent Performance

Glaxosmithkline Pharmaceuticals Ltd has not been a consistent performer in the YTD and longer periods

3
Quartile
quartile-3
QTD
-2.57%
4
Quartile
quartile-4
Jun-Sep
-21.48%
1
Quartile
quartile-1
Mar-Jun
17.77%
2
Quartile
quartile-2
YTD
13.58%
3
Quartile
quartile-3
2024
18.41%
2
Quartile
quartile-2
2023
43.86%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry stock-summary
Inconsistent Performance

Glaxosmithkline Pharmaceuticals Ltd has not been a consistent performer in the YTD and longer periods

2
Quartile
quartile-2
QTD
-2.57%
4
Quartile
quartile-4
Jun-Sep
-21.48%
2
Quartile
quartile-2
Mar-Jun
17.77%
1
Quartile
quartile-1
YTD
13.58%
3
Quartile
quartile-3
2024
18.41%
2
Quartile
quartile-2
2023
43.86%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap stock-summary
Inconsistent Performance

Glaxosmithkline Pharmaceuticals Ltd has not been a consistent performer in the YTD and longer periods

3
Quartile
quartile-3
QTD
-2.57%
4
Quartile
quartile-4
Jun-Sep
-21.48%
2
Quartile
quartile-2
Mar-Jun
17.77%
2
Quartile
quartile-2
YTD
13.58%
3
Quartile
quartile-3
2024
18.41%
3
Quartile
quartile-3
2023
43.86%
Click on any of the quartiles for detailed breakdown
stock-summaryRisk Adjusted Returns v/s
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available